Literature DB >> 2196021

Prophylactic digitalization for thoracotomy: a reassessment.

A J Ritchie1, P Bowe, J R Gibbons.   

Abstract

A prospective, controlled, randomized clinical study of 140 patients undergoing elective thoracic operations over a period of 1 year in a regional referral unit was performed in which one group received digoxin and the other did not. The incidence of cardiac arrhythmia was compared in each group. Overall mortality was 5.7%. There was no significant difference in incidence of cardiac arrhythmia in each group, and we conclude that the prophylactic use of digoxin in elective thoracic operations should be revised.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196021     DOI: 10.1016/0003-4975(90)90094-m

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Incidence, severity and perioperative risk factors for atrial fibrillation following pulmonary resection.

Authors:  Jelena Ivanovic; Donna E Maziak; Sarah Ramzan; Anna L McGuire; Patrick James Villeneuve; Sebastien Gilbert; R Sudhir Sundaresan; Farid M Shamji; Andrew J E Seely
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-12

2.  Long acting β2-adrenocepter agonists are not associated with atrial arrhythmias after pulmonary resection.

Authors:  Keiji Yamanashi; Satoshi Marumo; Ryota Sumitomo; Tsuyoshi Shoji; Motonari Fukui; Toshiro Katayama; Cheng-Long Huang
Journal:  J Cardiothorac Surg       Date:  2017-05-19       Impact factor: 1.637

3.  Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery?

Authors:  Nikolaos Barbetakis; Michalis Vassiliadis
Journal:  BMC Surg       Date:  2004-06-11       Impact factor: 2.102

Review 4.  Supraventricular arrhythmias after thoracotomy: is there a role for autonomic imbalance?

Authors:  George Vretzakis; Marina Simeoforidou; Konstantinos Stamoulis; Metaxia Bareka
Journal:  Anesthesiol Res Pract       Date:  2013-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.